C. Kent Osborne

American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer

M. Elizabeth H. Hammond, Daniel F. Hayes, Mitch Dowsett et al. · Journal of Clinical Oncology · 2010 · 4.3K citations · Full text

Medicine, Cancer Biology, Oncology +14

Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer

Jennet Harvey, Gary M. Clark, C. Kent Osborne et al. · Journal of Clinical Oncology · 1999 · 2.1K citations

Medicine, Endocrinology, Oncology +17

Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy

X. Li, Michael T. Lewis, Jian Huang et al. · JNCI Journal of the National Cancer Institute · 2008 · 1.8K citations · Full text

Medicine, Cancer Biology, Cell Biology +17

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

Kathy S. Albain, William E. Barlow, Steven Shak et al. · The Lancet Oncology · 2009 · 1.4K citations · Full text

Medicine, Oncology, Breast Oncology +12

Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancer

Matthew D. Burstein, Anna Tsimelzon, Graham M. Poage et al. · Clinical Cancer Research · 2014 · 1.4K citations · Full text

Life Sciences, Molecular Biology, Oncology +17